Instrument Inactif

Communiqués Zosano Pharma Corp Nasdaq

Actions

US98979H1032

Communiqués

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

ZOSANO PHARMA CORP : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (form 8-K)	03/06/22	AQ
Zosano Pharma : Files Voluntary Petition for Relief Under Chapter 11 - Form 8-K	02/06/22	PU
ZOSANO PHARMA CORP : Termination of a Material Definitive Agreement, Bankruptcy or Receivership, Other Events, Financial Statements and Exhibits (form 8-K)	02/06/22	AQ
Zosano Pharma Files Voluntary Petition for Relief Under Chapter 11	02/06/22	AQ
ZOSANO PHARMA CORP : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)	18/05/22	AQ
Zosano Pharma Reports First Quarter 2022 Financial Results	16/05/22	AQ
ZOSANO PHARMA CORP MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	13/05/22	AQ
ZOSANO PHARMA CORP : Results of Operations and Financial Condition, Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)	13/05/22	AQ
Zosano Pharma Reports First Quarter 2022 Financial Results	13/05/22	AQ
ZOSANO PHARMA CORP : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)	05/05/22	AQ
Zosano Pharma Provides Corporate Update	02/05/22	AQ
Zosano Pharma : Provides Corporate Update - Form 8-K	30/04/22	PU
ZOSANO PHARMA CORP : Other Events, Financial Statements and Exhibits (form 8-K)	29/04/22	AQ
Zosano Pharma Provides Corporate Update	29/04/22	AQ
Zosano Pharma : Announces Reverse Stock Split Effective Today ZSAN common stock expected to begin trading on a split-adjusted basis on April 12, 2022 - Form 8-K	11/04/22	PU
ZOSANO PHARMA CORP : Material Modification to Rights of Security Holders, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits (form 8-K)	11/04/22	AQ
Zosano Pharma Announces Reverse Stock Split Effective Today	11/04/22	AQ
Zosano Pharma : Reports Fourth Quarter and Fiscal Year 2021 Financial Results - Form 8-K	17/03/22	PU
ZOSANO PHARMA CORP MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)	17/03/22	AQ
Zosano Pharma Reports Fourth Quarter and Fiscal Year 2021 Financial Results	17/03/22	AQ

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués Zosano Pharma Corp Nasdaq

Actions

US98979H1032

Communiqués

Filtres